Por favor, use este identificador para citar o enlazar este ítem:
http://conacyt.repositorioinstitucional.mx/jspui/handle/1000/8595| Compassionate drug (mis)use during pandemics: lessons for COVID-19 from 2009 | |
| Amanda Rojek Genevieve Elizabeth Martin Peter Horby | |
| Acceso Abierto | |
| Atribución-NoComercial-SinDerivadas | |
| https://doi.org/10.1101/2020.05.07.20094839 | |
| https://www.medrxiv.org/content/10.1101/2020.05.07.20094839v1 | |
| Background New emerging infections have no known treatment. Assessing potential drugs for safety and efficacy enables clinicians to make evidence-based treatment decisions, and contributes to overall outbreak control. However, it is difficult to launch clinical trials in the unpredictable environment of an outbreak. We conducted a bibliometric systematic review for the 2009 influenza pandemic to determine the speed, and quality of evidence generation for treatments. This informs approaches to high-quality evidence generation in this and future pandemics. | |
| bioRxiv | |
| 12-05-2020 | |
| Preimpreso | |
| Inglés | |
| Público en general | |
| VIRUS RESPIRATORIOS | |
| Versión publicada | |
| publishedVersion - Versión publicada | |
| Aparece en las colecciones: | Materiales de Consulta y Comunicados Técnicos |
Cargar archivos:
| Fichero | Tamaño | Formato | |
|---|---|---|---|
| Compassionate drug (mis)use during pandemics lessons for COVID-19 from 2009.pdf | 287.89 kB | Adobe PDF | Visualizar/Abrir |